US FDA Approved Omidenepeg Isopropyl Eye Drops for Reduction of Elevated IOP
The US Food and Drug Administration (FDA) has approved omidenepag isopropyl ophthalmic solution (OMLONTI) 0.002% eye drops for treating the elevated intraocular pressure (IOP) in patients with primary glaucoma. OMLONTI 0.002%, is a selective prostaglandin E2 receptor agonist that is indicated for the reduction of elevated intraocular pressure (IOP) in patients with ocular hypertension or […]
Continue Reading